Close Menu
iM.NewsiM.News

    Subscribe to Updates

    Get the latest creative news from FooBar about art, design and business.

    What's Hot

    Curiosity Rover Captures Rare Twilight Clouds on Mars

    November 20, 2026

    US Lawmakers Seek Stricter AI Chip Export Controls

    November 20, 2026

    TAP Air Portugal Adds Nonstop Porto Service from Washington Dulles

    November 20, 2026
    Facebook X (Twitter) Instagram
    iM.NewsiM.News
    Subscribe
    • Home
    • Lifestyle

      US, Mexico, Bolivia Lose Measles-Free Status as Global Cases Rise

      November 20, 2026

      The Opera Coat Trend Takes Over Winter Fashion

      November 20, 2026

      New Weight-Loss Drug Cuts Knee Pain in Half for OA Patients

      November 20, 2026

      Robert Pattinson and Suki Waterhouse Redefine Hollywood Power Couples

      November 20, 2026

      Reading Linked to 33% Lower Alzheimer’s Risk, Study Finds

      November 20, 2026
    • Relations

      US Lawmakers Seek Stricter AI Chip Export Controls

      November 20, 2026

      Trump Threatens Tax on US Tech Firms Building AI Data Centers Abroad

      November 20, 2026

      Former US National Security Adviser Jake Sullivan Confronted by Students at MIT

      November 20, 2026

      Xi Jinping’s Restraint: The Power of Not Acting in Shenzhen

      November 20, 2026

      EU and UK to Sign Reset Deal on Trade and Youth Mobility

      November 20, 2026
    • Technology

      Germany Proposes €25 Billion Buyout of TikTok Europe

      November 20, 2026

      AI Supply Chain Leaks 2 Million Secrets in Canary Test

      November 20, 2026

      Google to retire Nest app in January 2027

      November 20, 2026

      Microsoft Link to Windows Adds Second Screen Feature

      November 20, 2026

      Nothing Sets December 8 Date for AI Hardware Reveal

      November 20, 2026
    • Travel & Tourism

      TAP Air Portugal Adds Nonstop Porto Service from Washington Dulles

      November 20, 2026

      Oil Spills Threaten UAE and Oman Beaches Amid Hormuz Conflict

      November 20, 2026

      Aer Lingus to Retrofit A330 Fleet with Premium Economy and New Business Class

      November 20, 2026

      Sabre Targets AI Travel Bookings With New Connector

      November 20, 2026

      Riyadh Hotel Revenue Plummets 65% After Airport Attack

      November 20, 2026
    • Get in Touch
    iM.NewsiM.News
    Home»Lifestyle»Health»Pancreatic Cancer Pill Shrinks Tumours in Early Trial
    Health

    Pancreatic Cancer Pill Shrinks Tumours in Early Trial

    im.newsBy im.newsNovember 20, 2026No Comments3 Mins Read4 Views
    Facebook Twitter Pinterest LinkedIn Tumblr Email
    Laboratory vials of daraxonrasib pancreatic cancer pill next to medical equipment
    Photo: Haymanj / Wikimedia Commons, Public domain
    Share
    Facebook Twitter LinkedIn Pinterest WhatsApp Email

    Medical experts are describing a new daily medication as the most significant advance in pancreatic cancer treatment in decades. The drug, known as daraxonrasib, appears to shrink or eliminate tumours in patients with one of the deadliest forms of the disease. Early clinical trials revealed that cancer became undetectable on scans for one in 12 participants who received the pill alongside standard chemotherapy.

    Daraxonrasib Trial Results

    The study involved 61 patients recently diagnosed with advanced pancreatic cancer that had spread to other parts of the body. Over an average follow-up period of 18 months, tumours stopped growing in nearly all participants. More than 60 percent of the patients experienced a reduction in tumour size or complete disappearance of the cancer mass.

    Dr. Wungki Park from Memorial Sloan Kettering Cancer Center, who is involved in the trial, noted that the results were extremely encouraging. He stated that the team is seeing not only higher response rates but also deeper responses and a near doubling in the duration of disease control. These metrics suggest the potential for longer survival, although researchers emphasize that the drug is not yet a cure.

    Laboratories Scientific Services drug testing
    Photo: Unknown / Rawpixel, CC0

    Dr. Sam Godfrey of Cancer Research UK called the findings the biggest leap forward in decades for patients. He explained that the drug has found a way to target what was previously considered undruggable. This progress addresses a long-standing gap in treating pancreatic cancer, which has the lowest survival rate of all common cancers in the United Kingdom.

    Targeting KRAS Mutations

    Daraxonrasib functions as a KRAS inhibitor. It works by binding to and shutting off specific genetic mutations known as RAS. These mutations are present in the majority of pancreatic cancers and drive the rapid growth of tumours. The drug has already received approval in the United States for certain indications.

    Free microscope public domain CC0
    Photo: Unknown / Rawpixel, CC0

    Because similar RAS mutations occur in other types of cancer, including lung and ovarian cancer, the medication could potentially benefit a wider range of patients. Dr. Godfrey expressed hope that the early success seen in pancreatic cancer could be extended to these other diseases through further research.

    Professor Elena Garralda, who chairs a European cancer conference where the work is being presented, highlighted that the combined treatment could significantly improve overall survival. It may also extend the time before tumours begin to grow again. However, doctors stress that longer studies are necessary to determine if the cancers can be put into long-term remission.

    Statistics from Cancer Research UK indicate that there are approximately 11,500 diagnoses of the disease in Britain each year, resulting in around 10,200 deaths. Symptoms often include jaundice, itchy skin, unexplained weight loss, and fatigue. Most patients with advanced disease survive only months rather than years, making any extension of life highly valuable.

    NABL Accredited Clinical Pathology Laboratory in Kharghar Navi Mumbai Diagnostic Services
    Photo: Goleisureintl / Wikimedia Commons, CC BY 4.0

    The next phase of research will focus on larger patient groups to confirm these initial findings. Scientists aim to understand how long the drug can keep the disease at bay and whether it can lead to permanent remission in more cases.

    Source: BBC

    Clinical Trial daraxonrasib Health KRAS inhibitor medical breakthrough Oncology pancreatic cancer
    Share. Facebook Twitter Pinterest LinkedIn Tumblr Email
    Previous ArticleAnthropic IPO Valuation Hits $1.76 Trillion on Nasdaq Debut
    Next Article White House Cyber Director Sean Cairncross Ousted After Tech Outages
    im.news

    Related Posts

    Curiosity Rover Captures Rare Twilight Clouds on Mars

    November 20, 2026

    US Lawmakers Seek Stricter AI Chip Export Controls

    November 20, 2026

    TAP Air Portugal Adds Nonstop Porto Service from Washington Dulles

    November 20, 2026
    Leave A Reply Cancel Reply

    Latest Posts

    Curiosity Rover Captures Rare Twilight Clouds on Mars

    November 20, 20260 Views

    US Lawmakers Seek Stricter AI Chip Export Controls

    November 20, 20262 Views

    TAP Air Portugal Adds Nonstop Porto Service from Washington Dulles

    November 20, 20262 Views

    US, Mexico, Bolivia Lose Measles-Free Status as Global Cases Rise

    November 20, 20262 Views
    Stay In Touch
    • Facebook
    • Twitter
    • Pinterest
    • Instagram
    • YouTube
    • Vimeo
    Don't Miss

    Epstein List Phase 1: Full Flight Logs, Client List Released

    February 28, 2025 News Focus 247 Views

    In a stunning development that has sent shockwaves through political and entertainment circles, Attorney General…

    Microsoft Stock Joins Exclusive $4 Trillion Club After Blockbuster Cloud + AI Earnings

    July 31, 2025

    DOJ & FBI Find No Epstein Client List, Suicide Confirmed

    July 7, 2025

    Subscribe to Updates

    Get the latest creative news from SmartMag about art & design.

    About Us
    About Us

    We provide the daily life news. You find latest trendy news at our portal, from entertainment to economy or politics.

    We're accepting new partnerships right now.

    Email Us: info@im.news

    Facebook X (Twitter) RSS
    Our Picks

    Curiosity Rover Captures Rare Twilight Clouds on Mars

    November 20, 2026

    US Lawmakers Seek Stricter AI Chip Export Controls

    November 20, 2026

    TAP Air Portugal Adds Nonstop Porto Service from Washington Dulles

    November 20, 2026
    Most Popular

    Epstein List Phase 1: Full Flight Logs, Client List Released

    February 28, 2025247 Views

    Microsoft Stock Joins Exclusive $4 Trillion Club After Blockbuster Cloud + AI Earnings

    July 31, 2025208 Views

    DOJ & FBI Find No Epstein Client List, Suicide Confirmed

    July 7, 2025165 Views
    © 2026 I'm News. Designed by I'm News.
    • Home
    • Lifestyle
    • Relations
    • Travel & Tourism
    • Technology

    Type above and press Enter to search. Press Esc to cancel.